B1-04: DN-101-004: a multicenter, open label, dose ranging study of DN-101 (ASENTAR”) and docetaxel in patients with stage IIIB or IV non-small cell lung cancer (NSCLC) after platinum-based chemotherapy

Autor: West, Howard, Reyno, Leonard, Lee, Stella, Fehrenbacher, Louis, Cohn, Allen L., Hopkins, Judith O., Irwin, David H., Smith, David A., Boyd, Thomas E., Olsen, Mark R.
Zdroj: In Journal of Thoracic Oncology August 2007 2(8) Supplement:S334-S334
Databáze: ScienceDirect